TRELAVUS, created in 2011 (United Kingdom), from 1722 sister brands and 17478 competing brands. TRELAVUS is owned by GSK PLC, listed on the stock exchange of London Its International Securities Identification Number (ISIN) is GB00BN7SWP63. TRELAVUS belongs to the Drug Manufacturers business sector.